Analysts rate Clover Health Investments Corp with a consensus Buy rating and a 12-month average target price of $4.63.
Based on the Clover Health Investments Corp stock forecasts from 3 analysts, the average analyst target price for Clover Health Investments Corp is USD 4.63 over the next 12 months. Clover Health Investments Corp’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Clover Health Investments Corp is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Clover Health Investments Corp’s stock price was USD 2.53. Clover Health Investments Corp’s stock price has changed by -3.44% over the past week, +13.45% over the past month and -69.15% over the last year.
What we like:
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What we don’t like:
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.